Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products
Author(s) -
Michael Kwa,
Leah J. Welty,
Shuai Xu
Publication year - 2017
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2017.2762
Subject(s) - medicine , food and drug administration , cosmetics , personal care , adverse effect , drug , drug administration , administration (probate law) , intensive care medicine , pharmacology , family medicine , pathology , political science , law
Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products The US Food and Drug Administration (FDA) defines cosmetics as articles for beautification, cleansing, or altering physical appearance. There have been multiple public health controversies surrounding cosmetics involving lip balms,1 lipsticks,2 and eyelash makeups adulterated with prostaglandins.3 In 2014, the FDA began investigating WEN by Chaz Dean Cleansing Conditioners after directly receiving 127 consumer reports. The FDA later learned the manufacturer had already received 21 000 complaints of alopecia and scalp irritation.4 The product remains on the market with the FDA currently soliciting additional consumer reports. To encourage greater transparency and more reporting, the FDA’s Center for Food Safety and Applied Nutrition’s Adverse Event Reporting System (CFSAN), a repository of adverse events related to foods, dietary supplements, and cosmetics, was made publically available in 2016. Our objective was to examine adverse events in CFSAN to inform future policymaking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom